Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
66.23
+2.55 (4.00%)
At close: Oct 20, 2026, 4:00 PM EDT
66.20
-0.03 (-0.05%)
After-hours: Oct 20, 2026, 7:41 PM EDT
Vaxcyte Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $125 | Buy | Reiterates | $125 | +88.74% | Oct 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $120 | Buy | Maintains | $120 | +81.19% | Oct 12, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Maintains $82 → $102 | Buy | Maintains | $82 → $102 | +54.01% | Oct 9, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $67 → $85 | Hold | Maintains | $67 → $85 | +28.34% | Oct 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $130 → $146 | Buy | Reiterates | $130 → $146 | +120.44% | Oct 6, 2026 |
| Needham | Needham | Buy Reiterates $110 → $122 | Buy | Reiterates | $110 → $122 | +84.21% | Oct 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $146 | Buy | Maintains | $146 | +120.44% | Oct 5, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $163 | Buy | Maintains | $163 | +146.11% | Oct 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.